StonvexLoading…
StonvexStonvexStonvexCore line items from FTNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.85B | $6.80B | $4.89B | $3.17B |
Operating Income | $580.00M | $2.08B | $1.46B | $911.80M |
Net Income | $534.50M | $1.85B | $1.35B | $873.50M |
EPS (Diluted) | $0.72 | $2.42 | $1.75 | $1.13 |
Total Assets | $9.88B | $10.39B | $9.36B | $10.64B |
Total Liabilities | $8.89B | $9.15B | $8.63B | $8.58B |
Cash & Equivalents | $2.22B | $2.50B | $2.00B | $3.37B |
Free Cash Flow OCF − CapEx | $1.01B | $2.23B | $1.65B | $1.08B |
Shares Outstanding | 734.00M | 743.00M | 742.90M | 765.60M |